Skip to main content
Premium Trial:

Request an Annual Quote

The Cat Microbiome

A group of researchers, including the University of California, Davis' Jonathan Eisen, are seeking funds to study the microbiomes of cats for their Kittybiome project. According to their Kickstarter page, they want to see how the microbiome influences cat behavior and health.

Supporters of the project will receive a sampling kit as well as a questionnaire asking about their cat; those who want to support the project but don't have a cat can choose to have the microbiome of a shelter cat sequenced instead.

"With your help, we will create the largest database of microbiome data and other data (behavior, health, diet, breed, geography) on cats," Eisen and his colleagues say at their Kickstarter page.

The researchers add that participants will receive their cat's results, and they pledge to publish their results in an open-access journal. In addition to supporters' cats, they also plan to examine the microbiome of two famous cats — LilBub, who has its own genome sequencing effort, and Eleanor Clift's cat Preshie.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.